Clinical Trials Logo

Filter by:
NCT ID: NCT03807115 Active, not recruiting - Stroke Clinical Trials

Effects of an Educational Intervention on Rehabilitation Clinicians' Practices for Health-related Outcomes After Stroke

Start date: February 24, 2020
Phase: N/A
Study type: Interventional

The overall aim of this pilot study is to evaluate the feasibility of a study protocol for a future stepped wedge cluster randomized clinical trial (c-RCT) that will investigate the effects of an innovative KT intervention on 1) walking capacity and independence in ADL in patients undergoing rehabilitation after stroke (patient outcomes); and 2) clinicians' practice (i.e. use of 4 evidence-based stroke rehabilitation interventions: motor imagery/mental practice, rhythmic auditory stimulation gait therapy, task oriented training including fitness and mobility exercises and aerobic training) (provider outcome) aimed at improving walking capacity. The specific objectives are: 1) To evaluate the feasibility (effectiveness of clinician recruitment strategies, extent of losses to follow-up across sites, and data analysis plans) of the study protocol in terms of methodology (stepped wedge design is an innovative methodology); 2) To estimate intervention effect sizes on study outcomes (patient and clinician); 3) To evaluate the secondary outcome (clinicians' use of the 4 interventions) with regard to reliability and validity.

NCT ID: NCT03806803 Completed - Clinical trials for Clostridium Difficile Diarrhea

Multicentre Blinded Comparison of Lyophilized Sterile Fecal Filtrate to Lyophilized Fecal Microbiota Transplant in Recurrent Clostridioides Difficile Infection

Start date: March 21, 2019
Phase: Phase 2
Study type: Interventional

Fecal microbiota transplantation (FMT) is a treatment that restores the balance of gut bacteria and is the most effective treatment for patients who suffer from recurrent Clostridioides difficile infection (CDI) brought on by antibiotic use. Although highly effective, we do not understand how FMT actually works. Freeze-dried or lyophilized fecal microbiota transplant (LFMT) has been shown to be effective. Recently, filtered fecal slurry, free of any live bacteria, has also been shown to cure 5 such patients. The advantage of the filtered fecal slurry is that it may be safer to patients as it does not contain any live bacteria. We have conducted a pilot study comparing LFMT to lyophilized sterile fecal filtrate (LSFF) in 9 patients, and found that the success rate of treatment was 80% vs 75% in these 2 groups. Therefore we need to perform a larger multicenter study to compare LFMT to LSFF to determine the success rate of curing these patients.

NCT ID: NCT03806595 Completed - Clinical trials for Migraine in Children

A Pilot Study of Intranasal Lidocaine in Acute Management of Pediatric Migraine

Start date: July 3, 2019
Phase: Phase 1
Study type: Interventional

Headaches in children are very common and are a source of significant distress for the patient and their family. Migraines are the most common headache disorder in children and are associated with episodic pain and other symptoms such as nausea and sensitivity to light and sound that can impair a child's ability to participate in daily activities and lead to missed school or parental missed work. When home treatment fails to relieve symptoms, children often seek care in the emergency department (ED) where a limited number of treatment options exist; while largely effective, these rescue treatments currently all require needle insertion of an intravenous line, take time to administer, result in prolonged ED stays, and have potential unpleasant side effects. In adult patients, a number of studies suggest that lidocaine, a local anesthetic administered intranasally, may provide relief of migraine and migraine-like headache pain in minutes. This approach has the benefit of working quickly, not requiring a needle, and having fewer side effects as the medication acts locally on nerves in the nose. Intranasal lidocaine has not yet been studied in children for this purpose. This study will compare the use of intranasal lidocaine to placebo. The goal of this pilot study is to provide information to inform the sample size calculation for the definitive randomized controlled trial that will aim to measure the efficacy of intranasal lidocaine as an analgesic option for children age 7 years and older who present to the Pediatric ED with a chief complaint of migraine or post traumatic headache with migraine-like features. Secondary objectives will be to report on the frequency and severity of rebound headache between the two treatment groups, adverse events of the study drug, as well as the impact on healthcare utilization measures.The investigators hypothesize that children receiving intranasal lidocaine will have faster and more effective pain recovery compared to children receiving placebo and will be less likely to require the standard therapy for migraine headache. Given very few side effects reported in adult studies and the relatively benign nature of those reported, the investigators do not expect any major safety concerns in the study. It is also hypothesized that intranasal lidocaine will lead to shorter ED visits, thus reducing use of staff and hospital resources and saving money for the healthcare system as a whole.

NCT ID: NCT03806530 Completed - Clinical trials for End Stage Renal Disease

DIalysis Symptom COntrol-Restless Legs Syndrome Trial

DISCO-RLS
Start date: May 1, 2019
Phase: Phase 3
Study type: Interventional

The DISCO-RLS Trial is a randomized controlled trial to determine the safety and efficacy of pharmacologic therapy (ropinirole versus placebo and gabapentin versus placebo) for the treatment of Restless Legs Syndrome in patients with End Stage Renal Disease requiring hemodialysis.

NCT ID: NCT03806114 Recruiting - Clinical trials for Health-Related Quality Of Life

Dislocation Precautions

Start date: June 21, 2019
Phase: N/A
Study type: Interventional

This study is looking at the impact of giving patients precautions, or restrictions for movement, when undergoing a total hip replacement. Have of the participants will receive precautions, while the other half will not receive any precautions.

NCT ID: NCT03805906 Completed - Pain, Back Clinical Trials

Ultrasound-guided L5 Dorsal Ramus Block

USGL5DR
Start date: January 12, 2019
Phase:
Study type: Observational

This study will examine the accuracy of an ultrasound-guided L5 dorsal ramus block technique.

NCT ID: NCT03805841 Terminated - NSCLC Stage IIIB Clinical Trials

Study of Tarloxotinib in Pts With NSCLC (EGFR Exon 20 Insertion, HER2-activating Mutations) & Other Solid Tumors With NRG1/ERBB Gene Fusions

RAIN
Start date: March 13, 2019
Phase: Phase 2
Study type: Interventional

Open-label, Phase 2, single treatment arm, 3 cohorts

NCT ID: NCT03805711 Terminated - Clinical trials for Aortic Valve Stenosis

HLT Meridian Valve CE Mark Trial

RADIANT CE
Start date: July 12, 2019
Phase: N/A
Study type: Interventional

To evaluate the safety and performance of the HLT System in patients with symptomatic heart disease due to severe aortic stenosis who are judged by the Heart Team to be at Intermediate or High Risk for aortic valve replacement surgery.

NCT ID: NCT03804814 Terminated - Hepatitis C Clinical Trials

Motivational Interviewing for HCV Elimination

Start date: May 21, 2019
Phase: N/A
Study type: Interventional

This study addresses a difficult barrier to hepatitis C elimination, specifically development and maintenance of a productive relationship between the health care provider and patient to ensure both treatment success and engagement in harm reduction services. Improvements in these domains may be observed through the use of a technique called "Motivational Interviewing" (MI). The aim of this study is to determine whether a customized motivational interviewing curriculum by general primary care and addictions medicine primary care providers changes rates of curative hepatitis C therapy completion.

NCT ID: NCT03804151 Recruiting - Sedentary Behavior Clinical Trials

Long-term Evaluation of the FitSpirit Intervention

Start date: January 1, 2018
Phase: N/A
Study type: Interventional

This study evaluates the long-term effects of the FitSpirit extra-curricular, girl-only intervention on numerous health outcomes of adolescent girls.